Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

How much does smoking cessation (SC) medications impacts on the income of the attendees of a smoking cessation clinic? A cross-sectional study

Sofia Belo Ravara, Lucia Gil
European Respiratory Journal 2016 48: PA4602; DOI: 10.1183/13993003.congress-2016.PA4602
Sofia Belo Ravara
1Faculty of Health Sciences, University of Beira Interior, Covilha, Portugal
2Tobacco Treatment Unit, CHCB University Hospital, Covilha, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucia Gil
1Faculty of Health Sciences, University of Beira Interior, Covilha, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction: Promoting effective use of SC medications is a priority. Nevertheless, SC medications are reimbursed in a few countries.

Aim: To assess the cost of SC treatment; and how much it impacts on the income of smokers' attending a cessation clinic in Covilha, Portugal.

Methods: Questionnaire-based cross-sectional study systematically carried out during clinical interviews. Chi-square, Mann-Whitney tests and logistic regression were performed.

Results: Participants: 503 smokers; mean age 47 ± 12.5 years; 66% males; most belonged to low socioeconomic status (SES); 86% smoked boxed-cigarettes (BC); 13% roll-your-own (RYO). Mean consumption was 23 ± 10 cigarettes/day; median duration of smoking was 30 years. Nicotine dependence was high in 27.5% and moderate in 60% of smokers. The median of monthly income was 600€. According to the modality of medication prescribed, SC costs per month were: 1) varenicline 2 mg/day=€88.6; corresponding to 16.2% (95%CI:15.2-17.2) of their monthly income; 2) varenicline 2mg/day + 3 oral NRT/day NRT=€123.2; corresponding to 22.5% (95%CI:21.2-23.9) of their monthly income, p<0.05; 3) NRT patch 21 mg + NRT 6 oral/day=€161; corresponding to 29.4% (95%CI:27.7-31.2) of their monthly income, p<0.001. Despite that RYO smokers' income was significantly lower than BC smokers', the burden of medication on the income of RYO smokers was significantly higher than BC smokers (>2x).

Conclusions: SC medication represents a major burden on smokers' income, especially on RYO users and those socially disadvantaged. This may undermine smoking cessation, urging for the need for reimbursement of cessation medication.

  • Smoking
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
How much does smoking cessation (SC) medications impacts on the income of the attendees of a smoking cessation clinic? A cross-sectional study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
How much does smoking cessation (SC) medications impacts on the income of the attendees of a smoking cessation clinic? A cross-sectional study
Sofia Belo Ravara, Lucia Gil
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4602; DOI: 10.1183/13993003.congress-2016.PA4602

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
How much does smoking cessation (SC) medications impacts on the income of the attendees of a smoking cessation clinic? A cross-sectional study
Sofia Belo Ravara, Lucia Gil
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4602; DOI: 10.1183/13993003.congress-2016.PA4602
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Testing for factors associated with desire to quit smoking at an HIV/STI Clinic
  • Use of oral and nasal tobacco and asthma symptoms in a Nordic population
  • Waterpipe tobacco smoking may potentiate risk of fungal and bacterial infections
Show more 6.3 Tobacco, Smoking Control and Health Education

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society